| Perspectives, knowledge, and fears of cancer patients about COVID-19 DC Guven, TK Sahin, OH Aktepe, HC Yildirim, S Aksoy, S Kilickap Frontiers in oncology 10, 1553, 2020 | 68 | 2020 |
| Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality DC Guven, TK Sahin, HC Yildirim, E Cesmeci, FGG Incesu, Y Tahillioglu, ... BMJ Supportive & Palliative Care 14 (e1), e456-e461, 2024 | 36 | 2024 |
| Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factorkappaB (NF- B) pathway OH Aktepe, TK Şahin, G Güner, Z Arik, Ş Yalçin Turkish journal of medical sciences 51 (1), 368-374, 2021 | 31 | 2021 |
| PILE: a candidate prognostic score in cancer patients treated with immunotherapy DC Guven, HC Yildirim, E Bilgin, OH Aktepe, H Taban, TK Sahin, IY Cakir, ... Clinical and Translational Oncology 23, 1630-1636, 2021 | 22 | 2021 |
| Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy DC Guven, MS Aksun, TK Sahin, OH Aktepe, HC Yildirim, H Taban, ... Supportive Care in Cancer 29, 5417-5423, 2021 | 21 | 2021 |
| A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer DC Guven, TK Sahin, HC Yildirim, OH Aktepe, O Dizdar, S Yalcin Critical reviews in oncology/hematology 168, 103528, 2021 | 20 | 2021 |
| The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy DC Guven, TK Sahin, E Erul, IY Cakir, E Ucgul, HC Yildirim, OH Aktepe, ... Journal of Clinical Medicine 11 (15), 4523, 2022 | 11 | 2022 |
| Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors DC Guven, OH Aktepe, H Taban, BY Aktas, G Guner, HC Yildirim, ... Biomarkers in Medicine 15 (13), 1123-1130, 2021 | 8 | 2021 |
| Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors DC Guven, TK Sahin, MS Aksun, H Taban, OH Aktepe, NM Aksu, M Akkaş, ... Supportive Care in Cancer 29, 2029-2035, 2021 | 8 | 2021 |
| The platelet to lymphocyte ratio predicts overall survival better than the neutrophil tolymphocyte ratio in metastatic renal cell carcinoma OH Aktepe, G Güner, DC Güven, TK Şahin, FS Ardic, D Yüce, Şİ YalÇin, ... Turkish journal of medical sciences 51 (2), 757-765, 2021 | 8 | 2021 |
| The predictive value of red blood cell distribution width for survival outcomes of metastatic renal cell carcinoma patients treated with targeted therapy OH Aktepe, DC Guven, TK Sahin, HC Yildirim, B Celikten, HH Yeter, ... Nutrition and Cancer 73 (10), 1957-1963, 2021 | 7 | 2021 |
| Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic DC Guven, F Ceylan, IY Cakir, E Cesmeci, B Sayinalp, B Yesilyurt, ... Supportive Care in Cancer 29, 4159-4164, 2021 | 7 | 2021 |
| Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards DC Guven, I Eroglu, R Ismayilov, E Ulusoydan, OH Aktepe, ... Journal of Oncology Pharmacy Practice 28 (8), 1807-1811, 2022 | 6 | 2022 |
| Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma Aktepe OH, Güner G, Güven DC, Taban H, Yıldırım HÇ, Şahin TK Turk J Urol 47 (2), 113-119, 2021 | 6 | 2021 |
| The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy DC Guven, G Kavgaci, OH Aktepe, HC Yildirim, TK Sahin, S Aksoy, ... Journal of Oncology Pharmacy Practice 28 (4), 785-793, 2022 | 5 | 2022 |
| Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61 TK Sahin, OH Aktepe, FM Uckun, S Yalcin Anti-Cancer Drugs 31 (6), 609-616, 2020 | 5 | 2020 |
| 773P Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy HC Yildirim, DCC Guven, OH Aktepe, F Yilmaz, BY Aktas, G Guner, ... Annals of Oncology 33, S894-S895, 2022 | 4 | 2022 |
| THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy OH Aktepe, F Gundogdu, K Kosemehmetoglu, HH Yeter, S Aksoy, ... Irish Journal of Medical Science (1971-) 191 (4), 1561-1567, 2022 | 4 | 2022 |
| The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors DC Guven, OH Aktepe, MS Aksun, TK Sahin, G Kavgaci, E Ucgul, IY Cakir, ... Cancer Biomarkers 34 (2), 189-199, 2022 | 4 | 2022 |
| Splenic gaucheroma leading to incidental diagnosis of Gaucher disease in a 46-year-old man with a rare GBA mutation: a case report I Erdal, Y Yildiz, G Onal, OH Aktepe, SA Duzgun, A Saglam, SD Emre, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023 | 3 | 2023 |
